Isradipine Results
The results of the STEADY-PD III trial have now been published. There was no evidence that
The results of the STEADY-PD III trial have now been published. There was no evidence that
A study investigating the potential neuroprotective effects of statins in Progressive Supranuclear Palsy (PSP) has found they may be associated with less severe movement problems and a delay in disease onset.
A pre-clinical study has shown that low dose insulin administered through the nose can improve movement and help protect dopaminergic neurons from damage.
The SURE-PD trial has indicated inosine was effective at increasing urate levels and slowing disease progression in women, but not men.
AUDIO VERSION AVAILABLE.
Evidence from preclinical studies supports case for a clinical trial of cysteamine in PwP
Patient narratives shown to be used as marketing tool